September 6, 2019 / 5:10 AM / 3 months ago

BRIEF-Europe OKs Roche’S Tecentriq cocktail for non-small cell lung cancer

Sept 6 (Reuters) - Roche Holding AG:

* EUROPEAN COMMISSION APPROVES ROCHE’S NEW TECENTRIQ-BASED COMBINATION THERAPY AS AN INITIAL TREATMENT FOR MOST COMMON FORM OF ADVANCED LUNG CANCER

* ROCHE SAYS APPROVAL OF THE NEW TECENTRIQ-BASED COMBINATION EXPANDS TREATMENT OPTIONS FOR PEOPLE ACROSS EUROPE AFFECTED BY NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) Source text for Eikon: [here ] Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below